PHGE · BiomX Inc. · Executive Compensation
$1.27
-0.58 (-31.35%)
At close · Sep 11
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company's ability to continue as a going concern depends on its ability to obtain additional financing or to generate sufficient operating cash flows from its newly acquired subsidiaries, neither of which can be assured. These factors raise substantial doubt about the Company's ability to continue as a going concern. The condensed consolidated interim financial statements have been prepared on a going concern basis and do not include any adjustments that may result from the outcome of these uncertainties.”View the 10-Q filed Aug 19, 2026
Market Cap
$4.94M
Shares
2.67M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | Chief Executive Officer | $1,375,022 |
| Dr. Merav Bassan | Chief Development Officer | $642,330 |
| Marina Wolfson | Chief Financial Officer | $553,454 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | Chief Executive Officer | $1,078,592 |
| Dr. Merav Bassan | Chief Development Officer | $532,982 |
| Marina Wolfson | Chief Financial Officer | $351,552 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | Chief Executive Officer | $1,118,541 |
| Dr. Merav Bassan | Chief Development Officer | $590,931 |
| Marina Wolfson | Chief Financial Officer | $428,256 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | Chief Executive Officer | $1,041,542 |
| Dr. Merav Bassan | Chief Development Officer | $562,948 |
| Marina Wolfson | Chief Financial Officer | $396,243 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | Chief Executive Officer | $1,334,997 |
| Dr. Merav Bassan | Chief Development Officer | $689,610 |
| Assaf Oron | Chief Business Officer | $496,213 |
| Marina Wolfson | Chief Financial Officer | $444,377 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | Chief Executive Officer | $1,101,817 |
| Dr. Merav Bassan | Chief Development Officer | $730,837 |
| Dr. Sailaja Puttagunta | Chief Medical Officer | $713,859 |
| Assaf Oron | Chief Business Officer | $443,882 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | Chief Executive Officer | $936,565 |
| Dr. Sailaja Puttagunta | Chief Medical Officer | $726,485 |
| Assaf Oron | Chief Business Officer | $455,692 |
| Dr. Merav Bassan | Chief Development Officer | $354,810 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Jonathan Solomon | Chief Executive Officer | $604,553 |
| Assaf Oron | Chief Business Officer | $322,799 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Roy Rousso | Chief Business Officer | Appointed | 2026-05-28 |
| Amir Shalom | Chairman of the Compensation Committee | Appointed | 2026-03-06 |
| Guy Arieli | Audit Committee member | Appointed | 2026-03-06 |
| Shaked Ran | Audit Committee member | Appointed | 2026-03-06 |
| Liat Bidas | Chairperson of the Audit Committee | Appointed | 2026-03-06 |
| Amir Shalom | Class I Director | Appointed | 2026-03-06 |
| Russell Greig | Board | Resigned | 2026-03-06 |
| Michael Oster | Chief Executive Officer | Appointed | 2026-03-06 |
| Russell Greig | Chairman of the Board | Resigned | 2026-03-06 |
| Jonathan Solomon | board of directors | Resigned | 2026-03-06 |
| Jonathan Solomon | Chief Executive Officer and Chief Principal Officer | Resigned | 2026-03-06 |
| Susan Blum | Board of Directors | Resigned | 2026-03-02 |
| David Rokach | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Appointed | 2026-03-02 |
| Edward Williams | Board of Directors | Resigned | 2026-03-02 |
| Greg Merril | Board of Directors | Resigned | 2026-03-02 |
| Merav Bassan | Chief Development Officer | Resigned | 2026-03-02 |
| Marina Wolfson | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Resigned | 2026-03-02 |
| Shaked Ran | Class III Director | Appointed | 2026-02-25 |
| Guy Arieli | Class I Director | Appointed | 2026-02-25 |
| Alan Moses | Board of Directors | Resigned | 2026-02-25 |
| Jesse Goodman | Board of Directors | Resigned | 2026-02-13 |
| Liat Bidas | Class II Director | Appointed | 2026-02-13 |
| Jonathan Leff | Board of Directors | Resigned | 2026-02-13 |
| Merav Bassan | Chief Development Officer | Terminated | 2026-02-10 |
| Marina Wolfson | Chief Financial Officer | Terminated | 2026-02-10 |